(Q44283775)

1 December 2017

title

Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells (English)

1 reference

1 December 2017

0 references

Kyoung Suk Choi

1

1 reference

1 December 2017

Tae Ho Lee

series ordinal

2

1 reference

1 December 2017

Myeong Ho Jung

series ordinal

3

1 reference

1 December 2017

publication date

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

10

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

87-95

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700531

1 December 2017

exact match

0 references

cites work

Apoptosis by death factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

An evolutionary perspective on apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

IAP family proteins--suppressors of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Expression of survivin and Bcl-2 in the normal human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

21 January 2018

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Pleiotropic cell-division defects and apoptosis induced by interference with survivin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Cancer gene therapy using a survivin mutant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Substrate sequence effects on "hammerhead" RNA catalytic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

Catalysis of RNA cleavage by the Tetrahymena thermophila ribozyme. 2. Kinetic description of the reaction of an RNA substrate that forms a mismatch at the active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Anti-apoptosis gene, survivin, and prognosis of neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Development of ribozymes for gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Toward a Broad-Based Antisense Technology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700531

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700531

1 reference

1 December 2017

1 reference